Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-RABV G/Glycoprotein Polyclonal Antibody

Catalog #:   PVV03902 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: AAG34721.1
Overview

Catalog No.

PVV03902

Species reactivity

Lyssavirus rabies

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant RABV G/Glycoprotein (Lys20-Glu458).

Tested applications

ELISA: 1:4000-1:8000, WB: 1:1000-1:4000

Target

glycoprotein, glycoprotein

Purification

Purified by antigen affinity column.

Accession

AAG34721.1

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with G/Glycoprotein antibody (PVV03902) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 52 kDa
    Observed MW: 52 kDa
References

Development and validation of a blocking ELISA for measurement of rabies virus neutralizing antibody., PMID:40366189

Rabies vaccination induces a CD4+ TEM and CD4+CD8+ TEMRA TH1 phenotype in dogs., PMID:40354406

Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein., PMID:40284919

Immunogenicity of Rabies Virus G-Protein mRNA Formulated with Muscle-Targeting Lipid Nanoparticles in Mice., PMID:40266088

Rabies virus large protein-derived T-cell immunogen facilitates rapid viral clearance and enhances protection against lethal challenge in mice., PMID:40251380

Molecular basis of two broad-spectrum antibodies neutralizing rabies virus and other phylogroup-I lyssaviruses by blocking structural transition between the pleckstrin-homology and fusion domains in the glycoprotein., PMID:40154685

Construction and evaluation of recombinant rabies virus encoding three copies codon-optimized G genes as inactivated rabies vaccine in dogs and cats., PMID:40112690

A VSV-based oral rabies vaccine was sentineled by Peyer's patches and induced a timely and durable immune response., PMID:40022445

Metagenomic next-generation sequencing for etiological diagnosis of an unexpected rabies case with unclear exposure history., PMID:39994640

IL-16 exerts anti-rabies virus effects through CD9 on the surface of viral particles., PMID:39956243

Evaluation of the immune status of dogs vaccinated against rabies by an enzyme-linked immunosorbent assay using crude preparations of insect cells infected with a recombinant baculovirus encoding the rabies virus glycoprotein gene., PMID:39625902

Evaluation of one year immunity following rabies post-exposure prophylaxis in dog bite cases., PMID:39604401

Development of Human Monoclonal Antibodies With Broad Reactivity for Rabies Postexposure Prophylaxis., PMID:39601104

IL-7 promotes mRNA vaccine-induced long-term immunity., PMID:39550592

Structural insight into rabies virus neutralization revealed by an engineered antibody scaffold., PMID:39471803

A novel inactivated oral rabies vaccine with the incorporation of U-OMP19 enhances the immunogenicity by reducing viral proteins degradation and activating dendritic cells in a mouse model., PMID:39471657

Analysis of the antigenic and immunogenic properties of the native rabies virus glycoprotein purified by Lens culinaris lectin affinity chromatography., PMID:39413880

Self-assembling nanoparticle engineered from the ferritinophagy complex as a rabies virus vaccine candidate., PMID:39366932

A nucleoside-modified mRNA vaccine forming rabies virus-like particle elicits strong cellular and humoral immune responses against rabies virus infection in mice., PMID:39129566

Toward the Development of a Pan-Lyssavirus Vaccine., PMID:39066269

Comparison of 4 laboratory tests for the detection of bovine rabies viral infection in Paraguay: fluorescent antibody test, rapid detection test, histologic lesions, and RT-PCR., PMID:38653733

Immune response after oral immunization of goats and foxes with an NDV vectored rabies vaccine candidate., PMID:38408125

A rabies mRNA vaccine with H270P mutation in its glycoprotein induces strong cellular and humoral immunity., PMID:38262810

A modified recombinant adenovirus vector containing dual rabies virus G expression cassettes confers robust and long-lasting humoral immunity in mice, cats, and dogs., PMID:38164714

An mRNA vaccine against rabies provides strong and durable protection in mice., PMID:37954577

A novel mRNA rabies vaccine as a promising candidate for rabies post-exposure prophylaxis protects animals from different rabies viruses., PMID:37923181

Immunogenicity of rabies virus G mRNA formulated with lipid nanoparticles and nucleic acid immunostimulators in mice., PMID:37866995

A single immunization with core-shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs., PMID:37819147

Immunogenicity and Antigenicity of the Ectodomain of Rabies Virus Glycoprotein Stably Expressed in HEK293T Cells., PMID:37786447

Genomic Surveillance of Rabies Virus in Georgian Canines., PMID:37766204

Antiviral mechanisms of two broad-spectrum monoclonal antibodies for rabies prophylaxis and therapy., PMID:37638057

Characterization of a human-mouse chimeric monoclonal antibody targeting rabies virus glycoprotein., PMID:37493180

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses., PMID:37349310

Pseudotyped Viruses for Lyssavirus., PMID:36920698

Transferrin Receptor Protein 1 Is an Entry Factor for Rabies Virus., PMID:36779762

A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice., PMID:36761167

An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs., PMID:36371169

Development of a reporter gene assay for antibody dependent cellular cytotoxicity activity determination of anti-rabies virus glycoprotein antibodies., PMID:36346082

Structure of trimeric pre-fusion rabies virus glycoprotein in complex with two protective antibodies., PMID:35985336

A Novel Rabies Vaccine Based on a Recombinant Bovine Herpes Virus Type 1 Expressing Rabies Virus Glycoprotein., PMID:35755997

Structure of the rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody., PMID:35714192

A single dose of recombinant VSV-RABVG vaccine provides full protection against RABV challenge., PMID:35618603

Recombinant adeno-associated virus serotype 9 AAV-RABVG expressing a Rabies Virus G protein confers long-lasting immune responses in mice and non-human primates., PMID:35579916

Point Mutations in the Glycoprotein Ectodomain of Field Rabies Viruses Mediate Cell Culture Adaptation through Improved Virus Release in a Host Cell Dependent and Independent Manner., PMID:34696419

Toll-Like Receptor 4 Regulates Rabies Virus-Induced Humoral Immunity through Recruitment of Conventional Type 2 Dendritic Cells to Lymph Organs., PMID:34613801

Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model., PMID:34346765

An inactivated recombinant rabies virus displaying the Zika virus prM-E induces protective immunity against both pathogens., PMID:34086672

Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice., PMID:33985418

A rabies virus vectored severe fever with thrombocytopenia syndrome (SFTS) bivalent candidate vaccine confers protective immune responses in mice., PMID:33957572

Safe and effective two-in-one replicon-and-VLP minispike vaccine for COVID-19: Protection of mice after a single immunization., PMID:33882114

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-RABV G/Glycoprotein Polyclonal Antibody [PVV03902]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only